Valuation Fate Therapeutics, Inc.

Stocks

Market Closed - Nasdaq Other stock markets 16:00:00 2026-08-04 EDT			5-day change	1st Jan Change
2.570 ^USD	+2.80%		+10.78%	+161.55%

07-09	Fate Therapeutics Shares Rise After FDA Clears Investigational New Drug Application for FT839	MT
07-09	Fate Therapeutics Receives FDA Clearance Of Investigational New Drug Application For FT839 Product Candidate	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	5,587	980.4	368.8	187.9	113.3	299.6	-	-
Change	-	-82.45%	-62.39%	-49.04%	-39.69%	164.29%	-	-
Enterprise Value (EV)	4,971	544.2	53.6	-118.8	113.3	299.6	299.6	299.6
Change	-	-89.05%	-90.15%	-321.66%	195.41%	164.29%	0%	0%
P/E	-26.1x	-3.47x	-2.28x	-1.01x	-0.85x	-2.38x	-2.49x	-2.39x
PBR	8.25x	2.03x	0.98x	0.59x	-	-	-	-
PEG	-	-0.1x	0.1x	-	0x	0.4x	0.53x	-0.55x
Capitalization / Revenue	100x	10.2x	5.8x	13.8x	17.1x	57.1x	57.2x	68.5x
EV / Revenue	0x	0x	0x	-0x	0x	57.1x	57.2x	68.5x
EV / EBITDA	-0x	-0x	-0x	0x	-0x	-2.19x	-1.96x	-
EV / EBIT	-0x	-0x	-0x	0x	-0x	-2.12x	-1.91x	-1.67x
EV / FCF	-0x	-0x	-0x	0x	-0x	-2.98x	-2.42x	-2.23x
FCF Yield	-3.82%	-28.9%	-37.5%	-65.8%	-98.8%	-33.6%	-41.3%	-44.8%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-2.24	-2.91	-1.64	-1.64	-1.15	-1.082	-1.031	-1.076
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	55.85	96.3	63.53	13.63	6.646	5.247	5.236	4.375
EBITDA ¹	-211.1	-294.6	-172.2	-191.3	-134.8	-137	-153.2	-
EBIT ¹	-217	-308.4	-190.5	-210.3	-147.7	-141.3	-156.7	-179.8
Net income ¹	-212.2	-281.7	-160.9	-186.3	-136.3	-132.7	-148	-173.4
Net Debt	-615.9	-436.2	-315.2	-306.7	-	-	-	-
Reference price ²	58.510	10.090	3.740	1.650	0.983	2.570	2.570	2.570
Nbr of stocks (in thousands)	95,494	97,170	98,602	113,894	115,352	116,559	-	-
Announcement Date	2/28/22	2/28/23	2/26/24	3/5/25	2/26/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
FATE THERAPEUTICS, INC.	-2.38x	-	-	-.--%	300M
WUXI APPTEC CO., LTD.	18.74x	6.48x	13.34x	1.55%	62.53B
ARGENX SE	30.63x	7.64x	23.53x	0.05%	52.43B
BIONTECH SE	-12.71x	4.47x	-5.41x	-.--%	23.1B
INSMED INCORPORATED	-38.11x	12.23x	-36.05x	-.--%	21.4B
GENMAB A/S	24.53x	4.77x	15.5x	-.--%	17.76B
PHARMAESSENTIA CORPORATION	46.65x	18.92x	48.72x	0.08%	15.47B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-734.33x	34.85x	-3923.62x	-.--%	14.68B
EXELIXIS, INC.	17.67x	5.11x	11.91x	-.--%	14.08B
ARROWHEAD PHARMACEUTICALS, INC.	-27.59x	25.44x	-33.26x	-.--%	12.62B
Average	-67.69x	13.32x	-431.70x	0.17%	23.44B
Weighted average by Cap.	-34.38x	10.48x	-237.80x	0.43%